Prefer plain water, or add lemon, mint, or cucumber if you enjoy a little flavor
Alopecia Associated With the Use of Semaglutide and Tirzepatide: A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS) From 2022 to 2023
Documentation and record-keeping maintain detailed records of all quality control testing and results
Employer Impact Are employer-sponsored health plans required to cover GLP-1s for weight loss
A medicine only helps if the patient actually takes it. When looking at the next research steps for elecoglipron, Carroll said he would like to see a phase 3 clinical trial involving thousands of patients over a year or more, to see where the blood-sugar and weight effects actually land and hold
Maharjan R, Lim DS, Baik HJ, Park HE, Kim MS, Kim KH, et al